The ripple effect: Benefits and clinical application of SGLT2 inhibitors

AstraZeneca |

Chair: Stephan Jacob (GER)

13:30 – 13:35Chair welcome and introductionsStephan Jacob (GER)
13:35 – 13:45Charting the ripple effect: Redefining care with SGLT2 inhibitorsHiddo Lambers Heerspink (NLD)
13:45 – 14:40Into the clinic: The ripple effect of early intervention, optimization and collaborationRoopa Mehta (MEX)
Xavier Cos (ESP)
Hiddo Lambers Heerspink (NLD)
Stephan Jacob (GER)
14:40 – 14:55Panel discussionAll faculty
14:55 – 15:00Summary and closeStephan Jacob (GER)

Disclaimer: This non-promotional symposium is organized and funded by AstraZeneca for healthcare professionals only.